-
D-N-Acetylgalactosamine: Brain Glycoprotein Workflow
2026-09-12
D-N-Acetylgalactosamine provides a defined, high-purity reagent for water- or DMSO-based studies of glycoprotein constituents, brain heteropolysaccharides, and glycosylation pathways. It should not be selected for ethanol-based workflows or long-term storage of prepared solutions, and application-specific validation is required because no directly matched paper evidence is supplied.
-
IR-820 (New Indocyanine Green) In Vivo Imaging
2026-09-12
IR-820 (New Indocyanine Green) supports quantitative vascular mapping, tumor localization, and longitudinal near-infrared fluorescence imaging in living-animal research. This workflow also shows how to evaluate the dye alongside photothermal nanomedicine while keeping imaging evidence separate from therapeutic claims.
-
Promethazine HCl in Macrophage Research Workflows
2026-09-11
Promethazine HCl provides a practical way to connect H1-receptor blockade with ROS, lysosomal, autophagy, and host-defense readouts. This workflow separates direct histaminergic effects from broader phenothiazine-associated macrophage responses, helping researchers design stronger inflammation and intracellular-bacteria assays.
-
Torin2: Separate Growth Arrest From Cell Death
2026-09-11
Torin2 is a potent mTOR inhibitor for dissecting pathway suppression, growth arrest, and cell killing without conflating these biological outcomes. This guide applies a time-resolved assay framework from cancer pharmacology to improve interpretation in medullary thyroid carcinoma models and broader cancer research.
-
GSK-923295 for CENP-E Mitotic Studies
2026-09-10
GSK-923295 is a mechanistically focused CENP-E inhibitor for separating motor-dependent chromosome congression defects from broader centromere architecture phenotypes. This workflow combines dose-response profiling, live-cell imaging, fixed-cell microscopy, and CTCF-depletion comparisons for reproducible cancer research.
-
MLN4924 HCl Salt: Reliable Assay Workflows
2026-09-10
This scenario-driven guide explains how MLN4924 HCl salt, SKU A3629, can support mechanistic cell viability, proliferation, and cytotoxicity studies through controlled NEDD8-activating enzyme inhibition. It covers assay design, DMSO handling, interpretation, cross-domain applications, and practical supplier-selection criteria.
-
Propranolol Workflows for β-Adrenergic Research
2026-09-09
Build reproducible Propranolol assays for cardiovascular regulation, emotional memory modulation, and metabolic readouts with solvent-aware dosing and receptor-specific controls. This guide combines practical workflow design with troubleshooting and a cautious pharmacogenomic perspective.
-
Beyond Viability: Translating (+)-JQ1 Biology
2026-09-09
A thought-leadership guide to using (+)-JQ1 as a mechanistically precise BET bromodomain inhibitor while distinguishing growth arrest from cell death, connecting cancer assays with inflammation and BRDT biology, and building a stronger translational evidence package.
-
CD44 Metabolic Rewiring in IDH-Mutant Leukemia
2026-09-08
The reference study identifies CD44 as a metabolic dependency in IDH-mutant leukemia, linking adhesion signaling to pentose phosphate pathway activity, NADPH production, and R-2HG biosynthesis. Its isogenic CRISPR-based design provides a useful framework for separating IDH-driven biology from co-occurring lesions and for evaluating combination strategies alongside mutant IDH inhibition.
-
Arachidonic Acid Workflows for Immune & Lipid Studies
2026-09-08
A practical guide to using Arachidonic Acid as both an eicosanoid-biosynthesis substrate and a controlled perturbation tool for inflammation, immune signaling, and pharmacology assays. It translates recent humoral-immunity findings into reproducible workflows while addressing solubility, oxidation, vehicle effects, and pathway-specific interpretation.
-
Recombinant Human Growth Hormone in Chondrocyte Assays
2026-09-07
Build more interpretable chondrocyte experiments with a defined somatotropin input, dose-response planning, and IGFBP2–THBS1 pathway controls. This workflow translates recent ISS research into practical proliferation, differentiation, and signaling assays while highlighting stability and troubleshooting considerations.
-
Zosuquidar: A Transporter-Aware MDR Assay Strategy
2026-09-05
Zosuquidar and LY335979 are best interpreted through a transporter-aware framework that connects P-glycoprotein inhibition with exposure, tissue distribution, and assay context. This article translates recent pharmacokinetic evidence into practical strategies for studying multidrug resistance in cancer without overstating cross-disease findings.
-
Apicidin: From HDAC Mechanism to Translational Insight
2026-09-05
Apicidin is more than a conventional epigenetic tool. Its HDAC3-favored activity connects chromatin regulation with cancer-cell phenotypes, angiogenesis biology, and emerging reproductive-toxicity questions. This thought-leadership guide translates recent oocyte findings into practical assay strategy while defining the compound’s evidentiary boundaries and research-use value.
-
CH 223191 for Reproducible AhR Assays
2026-09-04
Learn how CH 223191 (SKU A8609) can improve interpretation of viability, proliferation, and cytotoxicity assays involving AhR activation. This scenario-based guide covers controls, solvent compatibility, pathway validation, data interpretation, and practical product-selection criteria for environmental toxicology research.
-
MARCH5 and Mitochondria-Derived Pre-Peroxisomes
2026-09-04
Zheng et al. identify the mitochondrial ubiquitin ligase MARCH5 as a key regulator of PEX3-containing vesicle budding during mitochondria-assisted de novo peroxisome biogenesis. Their results distinguish this selective trafficking function from general mitochondrial-derived vesicle production and clarify how MARCH5 contributes to peroxisome homeostasis.